BackIsracann Biosciences Overview

Isracann Biosciences Total Liabilities

Isracann Biosciences's total liabilities is $3.9M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$3.91M
↑ 751.44% YoYΔ $3.45M vs prior year quarter

Peer trimmed avg / median

Loading

Isracann Biosciences Total Liabilities History

Loading

Isracann Biosciences vs. peers: Total Liabilities Comparison

Loading

Isracann Biosciences Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Isracann Biosciences (IPOT.CN) FAQ

As of the most recent data (August 2022), IPOT.CN shows a total liabilities of $3.9M. That compares with $460K in the prior-year period — up 751.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IPOT.CN's total liabilities is now $3.9M (was $460K) — a 751.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Isracann Biosciences is outperforming or lagging.

Tracking IPOT.CN's total liabilities over time shows whether Isracann Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $3.9M That compares with $460K in the prior-year period — up 751.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Isracann Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $3.9M) with ownership activity and broader fundamentals.